Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is about as under the radar a nice little company can be. Zero interest here............sad they can't stir up any institutional interest here at all........got to question mgt. at this point....
TIMBER SOON....Struggling to hold its own even with the deceiving bid support....
PCFG.....almost 400 million shares changed hands today.....see a move back to .0006 soon...
This will creep up much higher over time. DARA has multiple approved products available in the market now and will take advantage of further synergies as they are all oncology support. Plus, the drug in development, particularly KRN5500 can be a homerun.
Dara.....should make a move towards a buck soon.
Please be careful with outright lies and this is moving on up and not selling on the news....
I think many are confused here. This is not a one trick pony. They already have approved oncology products and as they draw in revenues this company will be profitable and that greatly mitigates the risk of any one drug in development not ending up being another blockbuster. This one is a winner for sure........and will see partnerships for certain...
Well this thing will turn up soon......sorry but they still have a launch of the Gelclair product on track for this month & ODD could be announced any day.
PCFG? Not looking like this is anything but a continued dilution scam. I now it has a cult following of folks who continue to hope in the face of relentless selling....
EPAZ...just can't seem to get over the hump for a breakout.....although the bevy of news suggests a plan.......
BUYER BEWARE>>>>THIS IS A SCAM THAT IS BEING PUMPED.
Why is there a need for another container. The same sites selling this incense still have ample inventory.....
Look folks...we've been through the lies of 7 eleven and everythnig else here before.....wrong one to pump IMO>.....
Ok...I would like to remind folks that every pump on HCPS has been a short lived failure only amplified by Mel's continued dilution.
Exactly what preparations are involved in planning for receipt of the container. I believe that is an out and out lie and was probably put out by someone involved in the one morning pump..... Buyer beware....we've been there done that before with HCPS........
ONTY....folks have suggested they might get compassionate use ok based on Merck's subset analyses to be shared at ASCO. Regardless of what the STIMUVAX subsets show.....they are apparently well on the way to a better vaccine that elicits both immuno and cellular response......They have great scientists....I just think the long development time for Stimuvax hurt them, as science marches on, and they now have even a better one...with that said...believe ASCO will show very good effects in certain non late stage cancer.....
Yes sir ... Time to move
Agree
The other more significant merger....
what was it then???
What is the timeline for merger news????
Never ending sell pressure on this one....really sucks
enough already please........
The secret is to have enough money so you don't need to get frustrated with dips and can wait for the big move patiently...and add cheapies
Low Trade..... great board you have here.......see you've been spot on with many calls.........learned a bit from reading your posts. I'd like to believe EPAZ has a move to the upside ahead but not sure with Iron Ridge.....they can be the driver or the hindrance.....
It won't work out as Gelclair is being launched this month as well...
Its going to go big....a few panickers bail on a short lived stall........
Interesting
I think you see through the real character of some of these big bio traders as when they unload they could give two about anyone else instead of methodically exiting a position....they cut bait and pull the rug from everyone else.... Plus you can read messages where these folks drool about the upcomings of a company only to reverse course if the trade goes south...
As DARA is approaching uncharted waters w/ their application pending in terms of timeline, it is fair to suggest the FDA sees the merits but sent mgt back to the drawing board as they obviously incompently bungled the filing by failing to satisfactorily justify the request.
DARA continues to sell off on a daily basis.....disappointing and a poorly managed company considering their oncology portfolio.
Agreed and what is also unique is the very poor job mgt. has done building share value for a seemingly robust oncology portfolio.....did I hear Donad Trump...........your fired mgt.!!!!!
Well hitting my radar now....
You know what...see you at a reverse split again and delisting warnings if they can't get their ass in gear...
I saw the CEO in an online interview and was not overly impressed....Not sure what incentived Jason Napadano and others to drool over the prospects as this company seemingly couldn't properly file a simple application
Look anytime a company bungles a submission its on mgt. 99.9 % of these are decdied within 120 days by the FDA. DARA's is the .01%......it is likely the FDA wants to approve it but mgt. probably did a very poor job of establishing they met the criteria and were asked to amend. That is on mgt.. Could be wrong but doubt it.....
I wonder how the CEO spends his day........shameful monetization of the company's drug assets so far........
DARA......just slowly selling off because the decision on Orphan status is taking longer than many hoped......which is being interpreted as a NO is forthcoming from the FDA.
Mgt. leaves lots to be desired IMO....as the submission obviously needed clarification per their IR and I bet it had to do with the population. I wonder if Napadano and others will back track on their view of DARA.
I do think they will get approval..
Perhaps....but right now a see another in the endless stream of small bios who tease but never close a partnership. They cannot proceed with additional trials w/o a partner. What is the CEO waiting for......time passes those by who cannot act.......
Well I thought I saw somewhere in the company presentation that their subset was approx. 230k lives as opposed to the less than 200k criteria. Perhaps they fined tuned that will the consultants help. We shall see....
I believe they've heard or their drug is the exception to the hundreds processed in the window........which is really not believable....
This company must get out of its own way and partner so they can move their products forward in the marketplace. These small bios never learn, their stubbornness to make the 'right deal' often extends on so long that the useful life of their products has diminished greatly w/ newer options. These clowns from DARA need to strike while the iron is hot.....or be added to the list of small bio busts. They can't move anywhere w/o a deal.....I think you will start to see the believers hedge if they do not take action SOON...